top of page

innovate.collaborate.change

EVIDENCE BASED ADVOCACY

how we’re different  the cancer collaborative (colab) is a hub for the cancer community. created to foster an environment of collaboration amongst science, policy and advocacy in order to make a meaningful contribution to cancer care.  our goal is to co-create and collaborate with stakeholders to proactively identify the challenges and opportunities, prioritize them and work together to make action-oriented changes on how cancer care is delivered in canada and beyond. better outcomes for cancer patients in canada can only be achieved when we let go of old ideologies- embracing innovation, encouraging collaboration, creating collective purpose and fundamentally changing. bold ideas and fuelling dialogues that adapt and adopt to shifting paradigms.

colab.conversations

COLAB.CONVERSATIONS IS AVAILABLE EVERYWHERE YOU GET YOUR FAVOURITE PODCASTS

US_ListenOn_AmazonMusic_Button_US_White.png
iHR_primary_White.png

LEARN MORE

coLAB(oratory)

car t-cell therapy is highlighting the necessity for a more flexible and nimble process to introduce innovation into our health and cancer systems, and the urgent need for stakeholders to work collaboratively to accelerate the introduction of innovative medicines.

CAR T-CELL THERAPY

precision medicine has the potential to change the way we think about, identify and manage cancer care. precision medicine and biomarkers will transform the delivery of cancer care to benefit both patients and cancer care systems.

PRECISION MEDICINE

MAKING CANCER A POLITICAL PRIORITY

using lessons learned from covid19 to prioritize cancer care in canada. 

examining the response to COVID19 and explore how it can be used to inform a renewed political effort to address the growing burden of cancer. 

PATIENT ENGAGEMENT IN HTA

using lessons learned from covid19 to prioritize cancer care in canada. 

examining the response to COVID19 and explore how it can be used to inform a renewed political effort to address the growing burden of cancer. 

HER'd

using lessons learned from covid19 to prioritize cancer care in canada. 

examining the response to COVID19 and explore how it can be used to inform a renewed political effort to address the growing burden of cancer. 

featured
ARTICLES

A LETTER TO THE DECISION MAKERS WHOSE DECISIONS CAN IMPACT THE LIVES OF CANADIANS LIVING WITH CANCER

healthinsight.ca | MacLean's

OPINION. WHY GENDER DISPARITIES IN HEALTH MATTER. INTERNATIONAL DAY OF WOMEN AND GIRLS IN SCIENCE

healthng.ca

OPINION. COVID19 AS A BLUEPRINT FOR HEALTHCARE TRANSFORMATION

healthig.ca

OPINION. CAR T-CELL THERAPY DELAYS JEOPARDIZE THE LIVES OF CANADIANS WITH BLOOD CANCER

healthing.ca

ACCESS TO IMMUNOTHERAPY FOR HARD TO TREAT LYMPHOMA IMPROVING

Toronto Star | Health Insight

CELL AND GENE THERAPIES. Health system progress in moving from
cutting edge to common practice

the economist

CRISIS TO CATALYST.

USING LESSONS LEARNED FROM COVID19 TO PRIORITIZE CANCER CARE IN CANADA

The colab.paper highlights some of the notable achievements made during the COVID19 response in Canada. These lessons serve as a blueprint for revolutionizing cancer care and mitigating the impact of cancer.

colabXchange

LATEST POSTS

bottom of page